Caribou Biosciences (CRBU) Cash from Investing Activities (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.47% |
| Dec 31, 2025 | 65.61% |
| Sep 30, 2025 | -54.86% |
| Jun 30, 2025 | -51.33% |
| Mar 31, 2025 | 209.99% |
| Dec 31, 2024 | -39.93% |
| Sep 30, 2024 | 25.10% |
| Jun 30, 2024 | -7.65% |
| Mar 31, 2024 | 172.94% |
| Dec 31, 2023 | 54.04% |
| Sep 30, 2023 | -718.91% |
| Jun 30, 2023 | -46.56% |
| Mar 31, 2023 | 1,669.49% |
| Dec 31, 2022 | 114.03% |
| Sep 30, 2022 | 40.32% |
| Jun 30, 2022 | 80.62% |
| Mar 31, 2022 | 58.55% |
| Dec 31, 2021 | -8,913.52% |
| Sep 30, 2021 | -298.76% |
| Jun 30, 2021 | -2,100.00% |
| Mar 31, 2021 | 96.33% |
| Dec 31, 2020 | -14,900.00% |